Trial intelligence / Profile preview

PREVENT ICARUS: Intracoronary adenosine to prevent periprocedural myonecrosis in elective coronary angioplasty

2009-013681-92Phase 4Active

Sponsor
Azienda Ospedaliero-Universitaria Maggiore della Carità
Start
Nov 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in coronary arteriosclerosis comparing Adenosine arm with Placebo arm (2 arms). Primary endpoint: Periprocedural troponin I elevation. Started Nov 2009; status: active.

02

Drugs

adenosine
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on 2009-013681-92.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-013681-92.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call